Dr. Vishal Gulati is a physician-scientist and venture investor with a longstanding track record in healthcare and life sciences. He co-founded Recode Ventures in 2022, where he focuses on early-stage companies developing new therapeutic modalities and platform technologies in biotech and healthtech.
Vishal has backed over 40 companies addressing areas of significant unmet medical need, with products reaching patients in nearly 100 countries. His board experience spans both public and private companies across therapeutics, diagnostics, digital health, and medtech.
His academic training in medicine and biomedical sciences underpins his ability to identify breakthrough technologies at their earliest stages. He was among the first investors in emerging areas such as genomics, computational biology, and the intersection of imaging and machine learning.
At Recode, his portfolio includes Sensible Biotechnologies (computation mRNA design and production), Nanograb (gene targeting), Probably Genetic (rare disease diagnostics), LabGenius (antibody design), and Waypoint Bio (spatial biology in immuno-oncology). Earlier investments include Evonetix, Chemify, Infinitopes, Clue, Ieso Digital Health, Quit Genius, Zoe, Kheiron, Arctoris, Turbine, and Relation Therapeutics.
Before Recode, Vishal spent over 15 years at firms such as Molten Ventures (formerly DFJ Esprit), Atlas Venture, and Oxford Science Enterprises. He currently serves as an independent chair or member of investment committees for funds including KHP Ventures, Cancer Research UK Seed Fund, and the University of Cambridge Seed Fund.
He also advises research institutions and policy organisations including the Francis Crick Institute, Reuben College (University of Oxford), the British Heart Foundation, and RAND Europe.
Vishal trained in medicine in India, with postgraduate education and research at the University of Oxford and Imperial College London, where he was a visiting faculty member from 2003 to 2008. His academic honours include two Medical Research Council fellowships, the UNESCO MCBN Fellowship, and the Rhodes Scholarship.